source
- EU regulators endorse Eli Lilly’s oral GLP-1 pill orforglipronThe European Medicines Agency’s human medicines committee (CHMP) has given a positive opinion on Eli Lilly’s oral GLP-1 medication, orforglipron, providing the drug with EU regulatory backing. The…
- Ambrose Healthcare acquires AM-Pharma for up to €161 millionAmbrose Healthcare, a British rare‑disease specialist, announced it has completed the acquisition of Dutch biotech AM‑Pharma. The deal values the company at up to 161 million euros (about $181 mill…